Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Top scientist Professor Sir John Bell, former President of the Academy of Medical Sciences, claimed family doctors have ...

Inclisiran – now given the trade name Leqvio – has been recommended for approval by the CHMP as a treatment for hypercholesterolaemia or mixed dyslipidaemia, two common forms of elevated ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Novartis and NHS England have forged a pact to accelerate the access of its new cholesterol-lowering drug inclisiran for primary prevention of cardiovascular disease. Health Secretary Matt Hancock ...

The usual Leqvio (inclisiran) dosage for certain kinds of high cholesterol is 284 milligrams per 1.5 milliliters (mg/mL). Specific dosages may vary depending on factors like your individual ...